Yakov and Partners - In the media

A study by Yakov and Partners finds that the medical tourism market in Russia may reach USD 7.6 bn. To do this, it is necessary to eliminate key obstacles and review the national strategy in this area. Analysts noted that medical tourism — defined as "health—related travel" — is one of the fastest growing segments of the global health economy

The Russian pharma industry is ramping up capacities in pursuit of technological sovereignty and independence of imports. Prompted by external and internal challenges, the domestic pharma industry has to improve its margins. Monish Arora, a Yakov and Partners Director and Head of its Healthcare Practice, outlined a multi-pronged strategy to increase industry performance

Monish Arora listed the key challenges that hinder rapid growth in drug launches in Russia. Arora points out such significant deterrents as a lack of investments, heavy reliance on import, and drastic reduction in joint international clinical research from 367 projects in 2021 to only 18 in 2023. High interest rates on loans as well as technological and external restrictions contribute to the challenges encountered by the industry